96 related articles for article (PubMed ID: 15037339)
1. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.
Hill SK; Schuepbach D; Herbener ES; Keshavan MS; Sweeney JA
Schizophr Res; 2004 May; 68(1):49-63. PubMed ID: 15037339
[TBL] [Abstract][Full Text] [Related]
2. The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.
Selva-Vera G; Balanzá-Martínez V; Salazar-Fraile J; Sánchez-Moreno J; Martinez-Aran A; Correa P; Vieta E; Tabarés-Seisdedos R
BMC Psychiatry; 2010 Jun; 10():47. PubMed ID: 20550658
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis.
Millgate E; Hide O; Lawrie SM; Murray RM; MacCabe JH; Kravariti E
Psychol Med; 2022 Jan; 52(1):1-13. PubMed ID: 36415088
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study.
Millgate E; Kravariti E; Egerton A; Howes OD; Murray RM; Kassoumeri L; Donocik J; Lewis S; Drake R; Lawrie S; Murphy A; Collier T; Lees J; Stockton-Powdrell C; Walters J; Deakin B; MacCabe J
BMJ Open; 2021 Nov; 11(11):e054160. PubMed ID: 34824121
[TBL] [Abstract][Full Text] [Related]
5. Reward processing in schizophrenia: a deficit in the representation of value.
Gold JM; Waltz JA; Prentice KJ; Morris SE; Heerey EA
Schizophr Bull; 2008 Sep; 34(5):835-47. PubMed ID: 18591195
[TBL] [Abstract][Full Text] [Related]
6. Eye movements as predictor of cognitive improvement after cognitive remediation therapy in patients with schizophrenia.
Zhu J; Li J; Zhou L; Xu L; Pu C; Huang B; Zhou Q; Lin Y; Tang Y; Yang L; Shi C
Front Psychiatry; 2024; 15():1395198. PubMed ID: 38690204
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia.
Knížková K; Keřková B; Večeřová M; Šustová P; Jonáš J; Siroňová A; Hrubý A; Rodriguez M
Schizophr Res Cogn; 2024 Sep; 37():100311. PubMed ID: 38601889
[TBL] [Abstract][Full Text] [Related]
8. Examination of the Relationship Between the Theory of Mind, Neurocognitive Functions and Thought-Language Features in the Schizophrenia and Bipolar Affective Disorder I Groups.
Günay Yağci Z; Boztaş MH
Turk Psikiyatri Derg; 2023; 34(2):68-79. PubMed ID: 37357893
[TBL] [Abstract][Full Text] [Related]
9. Controllability of Functional Brain Networks and Its Clinical Significance in First-Episode Schizophrenia.
Li Q; Yao L; You W; Liu J; Deng S; Li B; Luo L; Zhao Y; Wang Y; Wang Y; Zhang Q; Long F; Sweeney JA; Gu S; Li F; Gong Q
Schizophr Bull; 2023 May; 49(3):659-668. PubMed ID: 36402458
[TBL] [Abstract][Full Text] [Related]
10. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits.
Zhao Q; Cao H; Zhang W; Li S; Xiao Y; Tamminga CA; Keshavan MS; Pearlson GD; Clementz BA; Gershon ES; Hill SK; Keedy SK; Ivleva EI; Lencer R; Sweeney JA; Gong Q; Lui S
Neuropsychopharmacology; 2022 Nov; 47(12):2024-2032. PubMed ID: 35260788
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Alterations and Acute Medication Treatment Effects on Brain Task-Related Functional Connectivity in Youth With Bipolar Disorder: A Neuroimaging Randomized Clinical Trial.
Li W; Lei D; Tallman MJ; Ai Y; Welge JA; Blom TJ; Fleck DE; Klein CC; Patino LR; Strawn JR; Gong Q; Strakowski SM; Sweeney JA; Adler CM; DelBello MP
J Am Acad Child Adolesc Psychiatry; 2022 Aug; 61(8):1023-1033. PubMed ID: 35091050
[TBL] [Abstract][Full Text] [Related]
12. Adverse Childhood Experiences and Neurocognition in Schizophrenia Spectrum Disorders: Age at First Exposure and Multiplicity Matter.
Kasznia J; Pytel A; Stańczykiewicz B; Samochowiec J; Preś J; Rachubińska K; Misiak B
Front Psychiatry; 2021; 12():684099. PubMed ID: 34305680
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.
Eum S; Hill SK; Alliey-Rodriguez N; Stevenson JM; Rubin LH; Lee AM; Mills LJ; Reilly JL; Lencer R; Keedy SK; Ivleva E; Keefe RSE; Pearlson GD; Clementz BA; Tamminga CA; Keshavan MS; Gershon ES; Sweeney JA; Bishop JR
Neuropsychopharmacology; 2021 Sep; 46(10):1802-1810. PubMed ID: 34145405
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives.
Hochberger WC; Eskridge CLM; Bishop JR; Reilly JL; Rubin LH; Keedy S; Gershon ES; Tamminga CA; Pearlson GD; Ragozzino M; Keshavan MS; Sweeney JA; Hill SK
Schizophr Res; 2020 Sep; 223():236-241. PubMed ID: 32829984
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Relationship between Performance on the University of California Performance Skills Assessment (UPSA) and Outcomes in Schizophrenia: A Systematic Review and Evidence Synthesis.
Szabo S; Merikle E; Lozano-Ortega G; Powell L; Macek T; Cline S
Schizophr Res Treatment; 2018; 2018():9075174. PubMed ID: 30687553
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment from early to middle adulthood in patients with affective and nonaffective psychotic disorders.
Mollon J; Mathias SR; Knowles EEM; Rodrigue A; Koenis MMG; Pearlson GD; Reichenberg A; Barrett J; Denbow D; Aberizk K; Zatony M; Poldrack RA; Blangero J; Glahn DC
Psychol Med; 2020 Jan; 50(1):48-57. PubMed ID: 30606277
[TBL] [Abstract][Full Text] [Related]
17. Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs.
Ohi K; Sumiyoshi C; Fujino H; Yasuda Y; Yamamori H; Fujimoto M; Shiino T; Sumiyoshi T; Hashimoto R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513630
[TBL] [Abstract][Full Text] [Related]
18. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.
Hochberger WC; Joshi YB; Thomas ML; Zhang W; Bismark AW; Treichler EBH; Tarasenko M; Nungaray J; Sprock J; Cardoso L; Swerdlow N; Light GA
Neuropsychopharmacology; 2019 Feb; 44(3):606-612. PubMed ID: 30377381
[TBL] [Abstract][Full Text] [Related]
19. Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum.
Rodrigue AL; McDowell JE; Tandon N; Keshavan MS; Tamminga CA; Pearlson GD; Sweeney JA; Gibbons RD; Clementz BA
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):992-1002. PubMed ID: 29759822
[TBL] [Abstract][Full Text] [Related]
20. A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.
Ohi K; Sumiyoshi C; Fujino H; Yasuda Y; Yamamori H; Fujimoto M; Sumiyoshi T; Hashimoto R
Front Psychiatry; 2017; 8():293. PubMed ID: 29312019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
